Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Paul Edward Gross currently holds 95,840 shares of Clovis Oncology, Inc. (CLVS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul Edward Gross has been a net seller of CLVS stock. They have purchased $0 and sold $425.0K worth of shares.
Paul Edward Gross's most recent insider trade was on Nov 2, 2022, when they sold 2,595 shares at $0.98 per share.
Paul Edward Gross serves as Executive at Clovis Oncology, Inc. (CLVS). They have executed 102 insider transactions totaling $425.0K over their tenure at the company.
Paul Edward Gross holds the position of Executive at Clovis Oncology, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Paul Edward Gross has shown a selling trading pattern, with $0 in total purchases and $425.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Paul Edward Gross was on Feb 2, 2021, when they sold $73.8K worth of CLVS shares. This transaction involved 9,255 shares at $7.97 per share.
Paul Edward Gross currently owns 95,840 shares of Clovis Oncology, Inc. (CLVS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Paul Edward Gross's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Paul Edward Gross has 102 Form 4 filings on record as an insider at Clovis Oncology, Inc..
Set alerts for Paul Edward Gross and 40,000+ other insiders.